Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001393905-12-000394
Filing Date
2012-07-23
Accepted
2012-07-23 17:25:10
Documents
9
Period of Report
2012-05-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT trab_10q.htm 10-Q 155136
2 CERTIFICATION trab_ex311.htm EX-31.1 7765
3 CERTIFICATION trab_ex321.htm EX-32.1 4278
  Complete submission text file 0001393905-12-000394.txt   1027798

Data Files

Seq Description Document Type Size
4 trab-20120531.xml EX-101.INS 73240
5 trab-20120531.xsd EX-101.SCH 9453
6 trab-20120531_cal.xml EX-101.CAL 4855
7 trab-20120531_def.xml EX-101.DEF 47323
8 trab-20120531_lab.xml EX-101.LAB 83809
9 trab-20120531_pre.xml EX-101.PRE 58446
Mailing Address 120 WALL STREET SUITE 2401 NEW YORK NY 10005
Business Address 120 WALL STREET SUITE 2401 NEW YORK NY 10005 866-284-9561
TheraBiogen, Inc. (Filer) CIK: 0001405286 (see all company filings)

EIN.: 980559606 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-53008 | Film No.: 12974985
SIC: 2834 Pharmaceutical Preparations